-
Ra Pharmaceuticals to Present at the RBC Capital Markets 2018 Global Healthcare Conference
-
Ra Pharma (RARX) PT Lowered to $18 at RBC Capital, 'RA101495 ph2 PNH update narrows market but looks viable'
-
RBC Capital Starts Ra Pharma (RARX) at Outperform

